Ian M Silverman

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Dna Damage Response

Top Venues

Molecular cancer therapeutics

NPJ precision oncology

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Michael S Nakazawa, Ian M Silverman, Victoria Rimkunas, Artur Veloso, Dominik Głodzik, Adrienne Johnson, Toshiro K Ohsumi, Shreyaskumar R Patel, Anthony P Conley, Christina Lynn Roland, Pamela T Soliman, Hannah C Beird, Chia-Chin Wu, Davis R Ingram, Rossana Lazcano, Dawon Song, Khalida M Wani, Alexander J F Lazar, Timothy Anthony Yap, Wei-Lien Wang, Jonathan A Livingston
Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas. Molecular cancer therapeutics (2024)
Meredith S Pelster, Ian M Silverman, Joseph D Schonhoft, Adrienne Johnson, Pier Selenica, Danielle Ulanet, Victoria Rimkunas, Jorge S Reis-Filho
Post-therapy emergence of an NBN reversion mutation in a patient with pancreatic acinar cell carcinoma. NPJ precision oncology 8 (1) (2024)
Michael S Nakazawa, Ian M Silverman, Victoria Rimkunas, Artur Veloso, Dominik Głodzik, Adrienne Johnson, Toshiro K Ohsumi, Shreyaskumar R Patel, Anthony P Conley, Christina Lynn Roland, Pamela T Soliman, Hannah C Beird, Chia-Chin Wu, Davis R Ingram, Rossana Lazcano, Dawon Song, Khalida M Wani, Alexander J F Lazar, Timothy Anthony Yap, Wei-Lien Wang, Jonathan A Livingston
Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas. Molecular cancer therapeutics 23 (7) (2024)
Michael S Nakazawa, Ian M Silverman, Victoria Rimkunas, Artur Veloso, Dominik Głodzik, Adrienne Johnson, Toshiro K Ohsumi, Shreyaskumar R Patel, Anthony P Conley, Christina Lynn Roland, Pamela T Soliman, Hannah C Beird, Chia-Chin Wu, Davis R Ingram, Rossana Lazcano, Dawon Song, Khalida M Wani, Alexander J F Lazar, Timothy Anthony Yap, Wei-Lien Wang, Jonathan A Livingston
Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas. Molecular cancer therapeutics 23 (7) (2024)
Michael S Nakazawa, Ian M Silverman, Victoria Rimkunas, Artur Veloso, Dominik Głodzik, Adrienne Johnson, Toshiro K Ohsumi, Shreyaskumar R Patel, Anthony P Conley, Christina Lynn Roland, Pamela T Soliman, Hannah C Beird, Chia-Chin Wu, Davis R Ingram, Rossana Lazcano, Dawon Song, Khalida M Wani, Alexander J F Lazar, Timothy Anthony Yap, Wei-Lien Wang, Jonathan A Livingston
Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas. Molecular cancer therapeutics (2024)
Meredith S Pelster, Ian M Silverman, Joseph D Schonhoft, Adrienne Johnson, Pier Selenica, Danielle Ulanet, Victoria Rimkunas, Jorge S Reis-Filho
Post-therapy emergence of an NBN reversion mutation in a patient with pancreatic acinar cell carcinoma. NPJ precision oncology 8 (1) (2024)
Meredith S Pelster, Ian M Silverman, Joseph D Schonhoft, Adrienne Johnson, Pier Selenica, Danielle Ulanet, Victoria Rimkunas, Jorge S Reis-Filho
Post-therapy emergence of an NBN reversion mutation in a patient with pancreatic acinar cell carcinoma. NPJ precision oncology 8 (1) (2024)
Michael S Nakazawa, Ian M Silverman, Victoria Rimkunas, Artur Veloso, Dominik Głodzik, Adrienne Johnson, Toshiro K Ohsumi, Shreyaskumar R Patel, Anthony P Conley, Christina Lynn Roland, Pamela T Soliman, Hannah C Beird, Chia-Chin Wu, Davis R Ingram, Rossana Lazcano, Dawon Song, Khalida M Wani, Alexander J F Lazar, Timothy Anthony Yap, Wei-Lien Wang, Jonathan A Livingston
Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas. Molecular cancer therapeutics 23 (7) (2024)
Timothy Anthony Yap, Elisa Fontana, Elizabeth K Lee, David R Spigel, Martin Højgaard, Stephanie Lheureux, Niharika B Mettu, Benedito A Carneiro, Louise Carter, Ruth Plummer, Gregory M Cote, Funda Meric-Bernstam, Joseph O'Connell, Joseph D Schonhoft, Marisa Wainszelbaum, Adrian J Fretland, Peter Manley, Yi Xu, Danielle Ulanet, Victoria Rimkunas, Mike Zinda, Maria Koehler, Ian M Silverman, Jorge Sergio Reis-Filho, Ezra Rosen
Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results. Nature medicine (2023)
Daniel Zingg, Jinhyuk Bhin, Julia Yemelyanenko, Sjors M Kas, Frank Rolfs, Catrin Lutz, Jessica K Lee, Sjoerd Klarenbeek, Ian M Silverman, Stefano Annunziato, Chang S Chan, Sander R Piersma, Timo Eijkman, Madelon Badoux, Ewa Gogola, Bjørn Siteur, Justin Sprengers, Bim de Klein, Richard R de Goeij-de Haas, Gregory M Riedlinger, Hua Ke, Russell W Madison, Anne Paulien Drenth, Eline van der Burg, Eva Schut, Linda Henneman, Martine H van Miltenburg, Natalie Proost, Huiling Zhen, Ellen Wientjens, Roebi de Bruijn, Julian R de Ruiter, Ute Boon, Renske de Korte-Grimmerink, Bastiaan van Gerwen, Luis Féliz, Ghassan K Abou-Alfa, Jeffrey S Ross, Marieke van de Ven, Sven Rottenberg, Edwin Cuppen, Anne Vaslin Chessex, Siraj M Ali, Timothy C Burn, Connie R Jimenez, Shridar Ganesan, Lodewyk F A Wessels, Jos Jonkers
Truncated FGFR2 is a clinically actionable oncogene in multiple cancers. Nature 608 (7923) (2022)
Mengge Shan, Xinjun Ji, Kevin A Janssen, Ian M Silverman, Jesse Humenik, Ben A Garcia, Stephen A Liebhaber, Brian D Gregory
Dynamic changes in RNA-protein interactions and RNA secondary structure in mammalian erythropoiesis. Life science alliance 4 (9) (2021)
Ian M Silverman, Antoine Hollebecque, Luc Friboulet, Sherry Owens, Robert C Newton, Huiling Zhen, Luis Féliz, Camilla Zecchetto, Davide Melisi, Timothy C Burn
Clinicogenomic Analysis of FGFR2-Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib. Cancer discovery 11 (2) (2020)